ArticleJAMA2011

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

Daniel C Link et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.